Spektron Using AI to Design Drugs

Spektron Systems of Little Rock is using artificial intelligence and machine learning to speed up drug discovery in a process that involves designing a new molecule that could be further developed into a new drug.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.